Clinical Trial Update: Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating arsenic trioxide in combination with ascorbic acid and melphalan in patients with multiple myeloma has completed, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Alkeran (melphalan)
• Ascorbic acid (Vitamin C)
• Trisenox (arsenic trioxide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Multiple Myeloma, Stem Cell Transplantation | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2009-07-14